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Department of Physics and Astronomy, and Department of Chemistry and Biochemistry, University of Delaware, Newark, DelawareABSTRACT The G-protein-coupled receptors (GPCRs) are a ubiquitous family of signaling proteins of exceptional pharmaco-
logical importance. The recent publication of structures of several GPCRs cocrystallized with ligands of differing activity offers
a unique opportunity to gain insight into their function. To that end, we performed microsecond-timescale simulations of the A2A
adenosine receptor bound to either of two agonists, adenosine or UK432097. Our data suggest that adenosine is highly dynamic
when bound to A2A, in stark contrast to the case with UK432097. Remarkably, adenosine finds an alternate binding pose in which
the ligand is inverted relative to the crystal structure, forming relatively stable interactions with helices I and II. Our observations
suggest new experimental tests to validate our predictions and deepen our understanding of GPCR signaling. Overall, our data
suggest an intriguing hypothesis: that the 100- to 1000-fold greater efficacy of UK432097 relative to adenosine arises because
UK432097 stabilizes a much tighter neighborhood of active conformations, which manifests as a greater likelihood of G-protein
activation per unit time.INTRODUCTIONThe G-protein-coupled receptor (GPCR) family comprises
some 800 distinct members that transduce signals in an
astonishing variety of physiological contexts. The rational
design of therapeutic ligands targeting GPCRs is hotly
pursued for the treatment of a wide array of conditions;
indeed, it is estimated that half of all drugs target GPCRs
(1). Our understanding of ligand binding and GPCR activa-
tion is advancing rapidly, thanks to recent successes in
determining the structures of several members of the family
(for a review highlighting recent progress in this field and its
utility for designing ligands to modulate function, see Con-
greve and Marshall (2)).
In this study, we focus our attention on the A2A adenosine
receptor. The adenosine receptor subfamily (comprising
four subtypes) is actively targeted for the treatment
of Parkinson’s disease, schizophrenia, inflammation, and
cardiac ischemia (3–5). In the attempt to elucidate the
connection between ligand binding and adenosine receptor
activation, investigators have taken a major step forward
with the publication of several antagonist-bound structures
(6–8) and, more recently, structures bound to three agonists:
UK432097 (9), adenosine, and NECA (10). Although the
crystal structures represent a crucial and timely advance,
several lines of evidence suggest that we must reckon with
ligand dynamics and conformational heterogeneity before
we can gain a comprehensive understanding of receptor
function. In this context, computational work has indicated
a direct connection between cholesterol binding and the
conformation of A2A (11), and dramatic consequences for
ligand binding have been confirmed independently bySubmitted February 16, 2012, and accepted for publicationMarch 22, 2012.
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0006-3495/12/05/2114/7 $2.00experiment (12). A comparison of the dynamics of the
A2A and A2B subtypes provided insight into subtype speci-
ficity (13). Published simulations of rhodopsin have re-
vealed ligand conformational heterogeneity (14), and the
role of binding-pocket hydration in receptor activation has
been studied in simulations of bovine rhodopsin (15) and,
more recently, in simulations of squid rhodopsin (16) and
the b2 adrenergic receptor (17). Extensive simulations of
the b2 adrenergic receptor have highlighted conformational
variability and its role in ligand binding (18) and G-protein
activation (17,19). Simulations of a cannabinoid receptor
have revealed binding of the ligand followed by conforma-
tional changes consistent with current models of GPCR acti-
vation (20).
Here, we present evidence from microsecond simulations
of A2A bound to two different agonists for conformational
variability of the receptor, which manifests as multiple
binding modes of the native ligand adenosine. This contrasts
starkly with the binding of a highly potent synthetic agonist,
UK432097, that is much less dynamic in the binding pocket
and therefore stabilizes the protein in a much tighter neigh-
borhood of conformations, perhaps explaining the 100-
to 1000-fold lower half-maximal effective concentration
(EC50) of UK432097 compared with adenosine (21,22). In
the adenosine case, the binding pocket is well hydrated,
and consequently the ligand must compete with water for
hydrogen (H)-bonds. In the UK432097 case, bulky aromatic
prostheses at the extracellular end of the ligand serve to plug
the binding pocket, keeping it relatively dry compared with
the adenosine bound receptor.METHODS
The initial structures for A2Aþadenosine and A2AþUK432097 were taken
from the Protein Data Bank codes 2YDO (10) and 3QAK (9), respectively.doi: 10.1016/j.bpj.2012.03.061
Microsecond Simulations of the A2A Adenosine Receptor 2115The 2YDO structure is missing residues 214–223, and the 3QAK is missing
residues 149–157 and has an inserted T4 lysozyme between residues 208
and 221. We excised the T4L and reconstructed these missing regions using
the corresponding parts of our previously published well-equilibrated A2A
structure (11).
We set up the systems using Maestro version 9.2 (23) as follows: First,
we embedded the protein (residues 3–310) in a palmitoyloleyol phosphati-
dylcholine (POPC) bilayer by aligning the structure to structure ID (3EML)
in the Orientations of Proteins in Membranes database (24) with at least
10 A˚ between the protein and its closest periodic image. Two cholesterol
molecules were included in the hypothesized cholesterol-binding site, as
described in previous work (11). The protein-membrane system includes
~90 POPC lipid molecules and ~9000 TIP3P water molecules in a box
~80 A˚  60 A˚  100 A˚. We modeled the protein using the CHARMM22
force field with cmap correction (25), the POPC lipid and cholesterol using
the CHARMM36 parameter set (26), the ligand using the CGenFF small-
molecule force field (27), and waters using with CHARMM version of
TIP3P. Relaxation and molecular-dynamics calculations were performed
with Desmond v. 30110 (28) as follows: We relaxed all of the systems
using a lipid-protein equilibration/relaxation protocol distributed with the
Schro¨dinger 2009 suite. We performed the production run under constant
pressure of 1 atm and a temperature of 310 K, thermostated and barostated
according to the Martyna-Tobias-Klein method (29), with a coupling
constant of 0.5 (2.0) ps for the thermostat (barostat). Hydrogen positions
were constrained by the M-SHAKE algorithm, allowing a time step of 2
fs. Long-range electrostatics were computed every time step by the particle
mesh Ewald (PME) method with a cutoff radius of 10 A˚ and tail correction.
In the PME method, we used 60 Fourier mesh points along each cell axis
and the complex-to-complex (c2c) transform option. We obtained two
trajectories (~1 ms each) for each system (A2Aþadenosine or
A2AþUK432097).
We obtained all of the molecular images using the Visual Molecular
Dynamics package (30). In Table 1, the mean-squared deviation (MSD)
values for the ligand center of mass (CoM) position are defined by
1=N
PN
i¼1ðri  ravgÞ2, where ri is the position vector of ligand CoM at
a frame i, and ravg is the position vector of ligand CoM averaged over
the total frames N in the time periods indicated in the table. MSD 5
s(MSD) values are reported in the table. We obtained s(MSD) using the
blocking method (31) (data shown in Fig. S1 of the Supporting Material).
The q-value is defined as arccosðui$uinitialÞ, where ui ðuinitialÞ is the unit
vector of the ligand axis at a frame i (at initial, 0 ms), and u is a vector in
the plane of the bicyclic core and is chosen so that it points toward the extra-
cellular side. In the table, hqi5
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
hðq hqiÞ2i
q
values are shown, where<>
means the average over the indicated time periods. We obtained the
H-bonding contacts shown in Table 2 by using a distance cutoff of 4.0 A˚
(where the distance between donor and acceptor is<4.0 A˚) and angle cutoff
of 25 (where 180, the angle of the donor-hydrogen-acceptor, is<25). We
obtained the p-stacking interactions by using a distance cutoff of 4.0 A˚
(where the CoM distance between the hexagon ring of Phe-168 and the
bicyclic adenine core is <4.0 A˚) and angle cutoff of 20 (where the angle
between the perpendicular axes of the two rings is <20). In the orienta-TABLE 1 MSD of CoM position and rotation (q) for adenosine or U
Adenosine
MSD (A
2
) 0.1–0.9 ms 10.67*
0.1–0.5 ms 10.925 1.89
0.5–0.9 ms 2.345 0.25
q (degree) 0.1–0.9 ms 1035 56
0.1–0.5 ms 655 50
0.5–0.9 ms 1405 29
Data are reported for two independent trajectories of each ligand. The first trajec
are reported in the second column. MSD5 s(MSD) and hqi5
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
hðq hqiÞ2i
q
v
Materials and Methods. The values indicated by an asterisk were observed to ntional autocorrelation (see Fig. 3), hnðtÞ$nðt þ DtÞiis calculated by
1=N
PN
i¼1ni$nj , where ni (nj) is unit vector of the ligand axis at a frame i
(j), i j ¼ Dt, and N ¼ ðlastframeÞ  ði jÞ (here, the initial frame 1 is
chosen at 0.1 ms and the last frame is at 0.9 ms), and n is the perpendicular
of the plane of the bicyclic core. We obtained the number of waters inside
a protein using Lightweight Object-Oriented Structure (LOOS) version
1.7.2 (32) (see Fig. 5). Here, the binding pocket was defined as a bounding
box for residues 88, 177, 249, 253, 274, and 278.RESULTS
Ligand dynamics
Fig. 1 compares the motion of the two ligands in the ligand-
binding site (ligand structures are shown in Fig. 2). The CoM
of adenosine clearly explores a significantly larger volume
compared with that of UK432097. To quantify this behavior,
we measured the MSD of the CoM of the ligand for four
trajectories: two trajectories with adenosine bound, and
two trajectories withUK432097 bound (Table 1). The picture
suggested in Fig. 1 is confirmed by the overall CoM MSD,
averaged over the entire trajectories. More complex behavior
was revealed, however, when we sought to compute the
statistical error of our MSD estimates. The errors reported
in Table 1 were calculated using the blocking approach first
published by Flyvbjerg and Petersen (31), known as the
F-P block method, which computes the variance of an esti-
mated quantity by considering larger and larger blocks of
data (see Fig. S1).When the blocks are independent, the esti-
mate of the variance converges, signaled by a plateau in a plot
of the estimated variance as a function of block size. The F-P
block averaging indicated convergence of the MSD estimate
for the second adenosine trajectory and the first UK432097
trajectory. In the other two cases, the F-P block averaging
did not show a strong signal of convergence. A closer exam-
ination showed that in each of these two cases, the ligand
dynamics are better considered as consisting of two parts,
characterized by distinctly different MSDs. This is evident
from the same analysis applied separately to the two halves
of each trajectory, reported in the second and third rows of
Table 1. Although the general conclusion is borne out by
this more-detailed analysis, we note that, given less data, it
may not be possible to distinguish between the adenosine
and UK432097 CoM MSDs (i.e., the second half of adeno-
sine trajectory 1 and the first half of UK432097 trajectory 2).K432097 bound to A2A
UK432097
7.915 1.51 0.885 0.07 2.81*
6.565 1.97 0.915 0.11 3.415 0.31
7.505 2.31 0.765 0.07 0.735 0.15
74 5 48 235 4 205 7
85 5 50 235 4 195 8
63 5 42 235 4 215 5
tory results are reported in the first column and the second trajectory results
alues (calculated over the indicated time periods) are shown, as defined in
ot converge by the F-P block averaging.
Biophysical Journal 102(9) 2114–2120
TABLE 2 H-bonding and p-stacking interactions of adenosine or UK432097 with A2A
A2A þAdenosine First % Second % þUK432097 First % Second %
Glu-13 O1 13 (22) 1 (3)
O2 6 (11) 2 (6)
Ile-66 N5 3 (22) 2 (11)
Ser-67 N5 12 (68) 21 (67)
N6 31 (72) 14 (62)
Thr-88 N3 7 (14) N4 24 (37) 50 (70)
O2 10 (52) 4 (34)
Phe-168 p-stack 29 13 p-stack 85 34
Glu-169 N3 5 (10) 4 (9) N5 10 (19)
O2 2 (3) N6 12 (19)
Asn-253 N3 5 (14) 4 (22) N3 2 (5) 17 (35)
His-278 O1 4 (10) 3 (9) O1 22 (51) 25 (49)
O2 3 (9) O2 3 (44) 7 (68)
Criteria used to define H-bonding and p-stacking are defined in Materials and Methods. Data are presented for two independent trajectories for each system.
The first trajectory results are shown in the column marked First, and the second trajectory results are shown in the column marked Second. For H-bonds, two
measurements are shown: one with an angular restriction and one without (in parentheses). The percentage shows how often the contact is formed, averaged
over the last 0.9 ms of simulation time. In some cases an H-bond may switch between two different donors or acceptors on a particular side chain, and in these
cases the percentage represents the fraction of time in which any H-bond is formed. The atoms on the ligands that are involved in the contacts (as defined in
Fig. 2) are listed.
2116 Lee and LymanThe orientational dynamics are also quite different in the
adenosine and UK432097 cases (see Table 1). This is an
interesting point because the orientation of the ligand in
the pocket partly determines the binding pose. Attaining
the correct pose is believed to be essential for effecting acti-
vation, and is therefore an important focus of crystal struc-
ture analysis and predictive docking calculations. The gross
orientation of the ligand was quantified by a vector in the
plane of the bicyclic core (see Fig. 2). The vector was
chosen so that it would point toward the extracellular side
when the ligands were in their crystallized poses. Taking
as a reference the initial orientation, we measured the
average angle to this reference and its standard deviation.
Consistent with our observation that UK3432097 is rela-
tively stable in the binding pocket, the ligand did not sample
multiple orientations. Adenosine, on the other hand, was
small enough to rotate within the binding pocket, andFIGURE 1 Motion of ligands (A) adenosine and (B) UK432097 when
bound to A2A. The instantaneous CoM positions of the ligand are marked
by black dots. In each figure, the ligand is shown by red sticks over the black
dots and its average CoM position is indicated by an arrow. The transmem-
brane helices are shown in different colors: red (H1), green (H2), blue (H3),
magenta (H4), cyan (H5), gray (H6), and orange (H7).
Biophysical Journal 102(9) 2114–2120frequently sampled poses that were inverted relative to the
crystal structure pose. This is reflected by an average angle
that differs significantly from the crystal structure orienta-
tion, together with a standard deviation that indicates signif-
icant fluctuations around the average.
The orientational dynamics of bound adenosine suggests
an experimental probe: The decay of polarization of fluores-
cent light emitted by the bicyclic core is sensitive to the
reorientational dynamics of ligand between absorption and
emission (33). To investigate whether the orientational
dynamics could be observed by time-resolved fluorescence
polarization spectroscopy, we considered the autocorrela-
tion of the vector normal to the plane of the bicyclic core.
Although the emission dipole is probably not exactly
perpendicular to the plane, our choice is a reasonable proxy
in the absence of more detailed information. Fig. 3 shows
that the autocorrelation of the UK432097 emission dipole
decays exponentially with a time constant of 17 ns for the
first trajectory (28 ns for the second trajectory), and appears
to decay to a nonzero long time limit. The fact that in theFIGURE 2 Structures of adenosine and UK432097. Marked atom
numbers correspond to H-bonds listed in Table 2.
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FIGURE 3 Orientational autocorrelation of (A) adenosine and (B)
UK432097. Data for two independent trajectories of each ligand are shown.
The first trajectory results are shown in solid circles and solid line, and the
second trajectory results are shown by open circles and dashed line.
The circles are obtained from hnðtÞ$nðt þ DtÞi, as defined in Materials
and Methods. The lines are exponential functions of f ðDtÞ ¼
a expððDt=tÞÞ þ b, fitted to the circles. The fitted decay constants t
for the adenosine case (A) are 78 ns (72 ns) for the solid (dashed) line,
and for the UK432097 case (B) are 17 ns (28 ns) for the solid (dashed) line.
FIGURE 4 Ligand-residue contact time series for A2Awith (A) adenosine
or (B) UK432097. A contact (heavy atom distance < 4 A˚) is indicated by
a thin vertical black line, and stable contacts appear as horizontal solid
black bars. The residues shown in Table 2 are indicated, with residues iden-
tified by mutagenesis to be important for ligand binding indicated by *, and
those that form the binding site for our hypothesized inverted pose indicated
by y. The vertical arrows indicate the transmembrane helices. The second
trajectory results are shown in Fig. S2.
Microsecond Simulations of the A2A Adenosine Receptor 2117long time limit the dipole never fully loses its memory is
typical of hindered motion, and thus is expected in this
case (33). The autocorrelation of adenosine, on the other
hand, is observed to lose its memory exponentially, with
a time constant of 78 ns for the first trajectory (72 ns for
the second trajectory). The dramatic difference in the long
time behavior, together with the timescale of the adenosine
orientational correlations (of the same order of the fluo-
rescence lifetime) suggests that the dynamics of the two
ligands can be distinguished by time-resolved fluorescence
polarization spectroscopy.Ligand-protein contacts
The dynamic character of adenosine suggests that the con-
tacts between the protein and ligand are dynamic as well.
Fig. 4 compares time series of ligand-protein contacts
between two trajectories of A2A bound to both ligands
(also see Fig. S2). A cursory glance shows that, overall,
the contacts that formed in the adenosine case are much
more transient than those in the UK432097 case, in accord
with the observations of Fig. 1 and Table 1. The only contact
that is clearly formed over a significant fraction in both
cases is the aromatic stacking between Phe-168 and the
bicyclic core of the ligands. This interaction is present in
all published structures of A2A cocrystallized with any
ligand (agonist (9,10) or antagonist (6)), and also has
a profound impact on the affinity of the receptor for bothagonists and antagonists (34). However, even this interac-
tion is formed only 29% of the time when A2A is bound to
adenosine, compared with 85% of the time for UK432097,
as shown in Table 2.
We observe that in comparison with the ring-stacking
interaction, H-bonds are much more transient, and con-
siderably more so in the adenosine-bound system. Of partic-
ular note are interactions between the ribose hydroxyls
(O1 and O2; atom numbering refers to Fig. 2) and Ser-277
and His-278, both of which are important for binding the
agonist CGS21680 (35). Because all orthosteric agonists
share the ribose moiety, and these hydroxyls are observed
in the crystal structures to form H-bonds with key residues
that have been determined to be essential to activation,
they bear consideration for their role in receptor activation.
Remarkably, in the adenosine case, these hydroxyls are in
contact with His-278 only ~10% of the time. Thus, if these
H-bonds are indeed essential to activation, our data sug-
gest that, from the single receptor point of view, adenosine
only transiently activates A2A. On the other hand, in the
UK432097 trajectory these contacts are formed roughly
half of the time. If we imagine an ensemble of receptors
bound to either adenosine or UK432097, our data together
with the mutagenesis data suggest that a significantly larger
fraction of the UK432097 ensemble is in an active confor-
mation compared with adenosine. The rest of the tabulated
H-bonds are consistent with the trend observed for the O1
and O2 hydroxyls, with the UK432097 H-bonds overallBiophysical Journal 102(9) 2114–2120
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FIGURE 5 Number of water molecules in the ligand-binding pocket of
A2A with adenosine or UK432097 bound. The binding pocket is defined
in Materials and Methods. The second trajectory results are shown in
Fig. S3.
2118 Lee and Lymanmore stably formed. The most stable of all were those in the
UK432097 case, formed between Ser-67 and the urea group
(atoms N5 and N6), and between Thr-88 and the ribose
hydroxyls and 50-ethyluronamide (atom N4). Thr-88 has
also been shown to be important for binding the agonist
CGS21680 (35). Remarkably, Thr-88 also interacts with
adenosine in our simulations, but with the ligand in an in-
verted pose, to which we now turn.
At ~500 ns in the first adenosine trajectory (indicated by
the vertical dashed line in Fig. 4), the ligand breaks its crys-
tallographically observed contacts and finds a new inverted
pose. The transiently formed H-bonds with Asn-253 and
His-278 on H5, H6, and H7 are broken, whereas new
H-bonds are formed between the ribose hydroxyls and
Glu-13 on H1, and between the exocyclic amide nitrogen
(N3) and Thr-88 on H3. Four residues on H2 (Ala-59,
Phe-62, Ala-63, and Ile-66) form a hydrophobic pocket
for the small hydrophobic moiety on the ribose. Interest-
ingly, the ring-stacking interaction with Phe-168 is re-
formed in the inverted pose, making it the only contact
that is common to both poses. The same pose is observed
in the second adenosine trajectory, though it is less stable
because the ligand samples a number of alternate con-
figurations, and therefore does not present a clear signature
in the contact time series (see Fig. S2). In both trajectories,
the ligand eventually spontaneously unbinds and escapes the
binding pocket into the solvent.FIGURE 6 Isosurface of water density in the ligand-binding pocket of
A2A with (A) adenosine or (B) UK432097. The water density is averaged
over 0.1–0.9 ms, and the isosurface with 0.3 of the bulk water density is
drawn in green. In each figure, H6 and H7 are marked by VI and VII,
respectively, the ligand is shown in red, and Asn-253 on H6 and His-278
on H7 are shown in blue. The portion of the ligand buried in isosurface
is rendered with thinner lines. The second trajectory results are shown in
Fig. S4.Binding-pocket hydration
Considering that the cost of breaking an H-bond is on the
order of a few times kBT, how is it that we see such transient
and dynamic H-bonds in the adenosine case? And why does
it differ so dramatically from the UK432097 case? We
suggest that the answer lies in the difference in the solva-
tion of the binding pocket, noting that previous work on
rhodopsin (15,16) and the b2 adrenergic receptor (17)
showed a connection between binding-pocket hydration
and ligand conformation and dynamics. In this case, we ex-
pected that the transient nature of H-bonds, especially those
formed with the ribose hydroxyls, would be due to compe-
tition with water in the binding pocket.
We first simply counted water molecules in the binding
pocket, defining the binding pocket by a rectangular volume
bounded by residues 88, 177, 249, 253, 274, and 278.
(Although the binding pocket is better defined by an irreg-
ular volume, incorporating such an irregular shape requires
a much more computationally demanding analysis, and
we expect the outcome will not qualitatively change the
results. Furthermore, we also present a volumetric map of
the binding-pocket water, which presents a spatially re-
solved analysis.) The data clearly indicate that significantly
more water is present in the binding pocket in the adenosine
case, as shown in Fig. 5. In the adenosine case, the data
appear to continue to trend upward, most likely because,Biophysical Journal 102(9) 2114–2120as mentioned earlier, the adenosine is in the process of
spontaneously unbinding. Nonetheless, we can estimate
the number of waters in the binding pocket by considering
the portion of the data from 100 ns to 900 ns, where the
UK432097 data appear converged and the adenosine is still
bound. We find that there are on average 73 waters in the
adenosine-binding pocket, and only 18 in the UK432097
case. These data are consistent with the crystal structure
data: nine water molecules were resolved in the binding
pocket in the adenosine case, compared with only two in
the UK432097 case. Data for two independent trajectories
are shown in Fig. S3 and are consistent with this analysis,
showing 57 waters in the adenosine case and 24 in the
UK432097 case.
Where exactly is the water in each case? In particular, is
water found deep in the binding pocket where it can
compete with the ribose hydroxyls? To answer this question,
we built a volumetric map of the water density, essentially
a three-dimensional histogram of the binding pocket
volume. The histogram is visualized in Fig. 6 and Fig. S4
Microsecond Simulations of the A2A Adenosine Receptor 2119as water density isosurfaces; in this case, every point con-
tained in the surface has an average water density at least
0.3 of the density of bulk water. From a comparison of the
isosurfaces, it is clear that there is significantly more water
in the vicinity of the ribose hydroxyls in the adenosine case
than in the UK432097 case, supporting the hypothesis that
competition with water for H-bonds is responsible for the
transient nature of the key ribose contacts in the adenosine
case. A comparison of the extracellular surfaces of the
protein in each case offers a possible explanation for the
difference: In UK432097, the aromatic appendages (see
Fig. 2) plug the entrance to the binding pocket, blocking
access of water to the interior of the protein. We revisit
this observation below.DISCUSSION
We have presented molecular-dynamics data for the adeno-
sine A2A receptor bound to either the native ligand adeno-
sine or a highly potent synthetic agonist, UK432097. In
two independent trajectories totaling 2 ms of data, adenosine
is found to be very dynamic in the binding pocket, as evi-
denced by the CoM motion and the orientational dynamics.
The dynamics of UK432097 as observed in two independent
trajectories totaling 2 ms contrast sharply with adenosine:
the CoM explores a much smaller volume, and the extended
nature of the ligand prevents significant orientational
dynamics while it is bound. The dynamics have conse-
quences for the contacts formed with the protein. Of special
significance are the H-bonds formed with the ribose
hydroxyls, which are thought to be crucial for activation
of the receptor. We find that in the adenosine case, the
binding pocket is much better hydrated, and that competi-
tion with water for H-bonds with the protein results in
much more transient H-bonds in the adenosine case and is
partly responsible for the observed difference in dynamics.
Our observations are corroborated by recent calculations
that suggested that caffeine may sample multiple poses
when bound to A2A (36), and by earlier simulations of
bovine rhodopsin (15), squid rhodopsin (16), and the b2
adrenergic receptor (17).
The dynamic nature of adenosine relative to UK432097
ought to have observable consequences. Our data suggest
that the reorientation dynamics of adenosine would not be
directly observable by a time-resolved measurement of the
loss of polarized fluorescence emission from the ligand.
Our simulations indicate that the reorientational dynamics
of adenosine occur on ~100 ns timescales, whereas the fluo-
rescence lifetime of adenosine is on the order of 10 ns. How-
ever, the difference between the adenosine and UK432097
cases may be detected because of the difference in the
long time limit arising from the hindered nature of the
UK432097 reorientation.
Our data also suggest the possibility of an additional
binding site located closer to the extracellular entrance tothe binding pocket, formed by Glu-13 on H1, Phe-168,
and a small hydrophobic pocket on H3. To our knowledge,
the role of Glu-13 in ligand binding has yet to be studied by
means of mutagenesis. It is possible that the proposed in-
verted pose is visited as the ligand binds, and thus mutagen-
esis of Glu-13 might reduce the on-rate for ligand binding. If
this notion is confirmed, Glu-13 and the small hydrophobic
pocket on H2 might serve as a target for allosteric control of
ligand binding, perhaps by incorporating a hydrophobic
plug much like the extracellular end of UK432097. Allo-
steric modulation of GPCR function is an area of very active
research (37). Allosteric modulators of adenosine receptor
function are known, but, by and large, the mechanisms by
which they exert their effects are not (5).
Finally, we argue that the 100- to 1000-fold lower EC50 of
UK432097 (21,22) provides evidence in support of our
observations, when viewed in the context of conformational
selection and its connection to G-protein activation. We
suggest that the difference in potency is explained by the
fact that UK432097, by forming more robust H-bonds
with the hydroxyl moiety, stabilizes a much tighter neigh-
borhood of active conformations, which manifests as an
increased likelihood of G-protein activation per unit time.
Adenosine, on the other hand, allows the receptor access
to a much broader range of conformations. We stress that
this hypothesis is based on experimental evidence for the
key role of the hydroxyl H-bonds in activation (34,35) and
the stark differences observed between the UK432097 and
adenosine cases, and not on any inference about the affinity
of the two ligands for the receptor. Perhaps the ensemble of
conformations that are stabilized by the native ligand is
promiscuous enough to be steered down different pathways
under different circumstances, for example, by a change in
the membrane environment or by dimerization with another
receptor. We intend to follow this lead in future work to
explore the hypothesis that there is a direct link between
conformational promiscuity and functional selectivity.SUPPORTING MATERIAL
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